OTCM
LUVU
Market cap2mUSD
Jul 09, Last price
0.04USD
1D
12.57%
1Q
25.76%
Jan 2017
20.00%
IPO
-87.14%
Name
Luvu Brands Inc
Chart & Performance
P/E
—
P/S
0.11
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.42%
Rev. gr., 5y
6.09%
Revenues
25m
+0.48%
Net income
-448k
L+12.28%
CFO
-410k
L
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Luvu Brands, Inc. is a global enterprise that develops, produces, and sells a diverse range of items focused on well-being, everyday living, and relaxed seating. The company offers the Liberator line, which includes products designed to enhance sexual performance. Additionally, under its Avana brand, it provides therapeutic bedding solutions aimed at alleviating discomfort from conditions like acid reflux, post-surgery recovery, and persistent pain. The Jaxx brand features daybeds, couches, and beanbag chairs, all crafted using both new and recycled polyurethane foam. The company also manufactures medical isolation gowns and face masks. Beyond creating its own products, Luvu Brands engages in the purchase and resale of merchandise to various outlets, including traditional retailers, online stores, and independent shops. It further provides contract manufacturing and order fulfillment services. Its products reach consumers through its dedicated online platforms (liberator.com, jaxxliving.com, and avanacomfort.com), as well as via a broad network of distributors, retailers, and e-tailers. These channels span diverse market segments, such as adult, mass-market, pharmaceutical, and specialty accounts. Founded in 1999, the company was initially known as Liberator, Inc., officially changing its name to Luvu Brands, Inc. in November 2015. Its corporate headquarters are located in Atlanta, Georgia.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||